'Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study' by Moltó et al: still a long way to go in the assessment of patients with spondyloarthritis and concomitant fibromyalgia?
- PMID: 29572290
- DOI: 10.1136/annrheumdis-2018-213319
'Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study' by Moltó et al: still a long way to go in the assessment of patients with spondyloarthritis and concomitant fibromyalgia?
Keywords: disease activity; fibromyalgis/pain syndromes; spondyloarthritis; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: ' "Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study" by Moltó et al: still a long way to go in the assessment of patients with spondyloarthritis and concomitant fibromyalgia?' by Altobelli et al.Ann Rheum Dis. 2019 May;78(5):e40. doi: 10.1136/annrheumdis-2018-213419. Epub 2018 Apr 3. Ann Rheum Dis. 2019. PMID: 29615409 No abstract available.
Comment on
-
Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study.Ann Rheum Dis. 2018 Apr;77(4):533-540. doi: 10.1136/annrheumdis-2017-212378. Epub 2017 Nov 28. Ann Rheum Dis. 2018. PMID: 29183878
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources